These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 335580)

  • 61. An evaluation of six new intrauterine devices.
    Boateng J; Chi IC; Jones DB
    Adv Contracept; 1994 Mar; 10(1):57-70. PubMed ID: 8030456
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Is the copper T 380A device associated with an increased risk of removal due to bleeding and/or pain? An analysis.
    Chi IC; Farr G; Thompson K; Acosta M; Alvarado G; Rivera R; Bandaragoda J; Delgado Betancourt J
    Contraception; 1990 Aug; 42(2):159-69. PubMed ID: 2085967
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative clinical experience with 3 IUDs, TCu 380 Ag, TCu 220C and Mahua ring, in Tianjin, People's Republic of China.
    Shih S; Li-Juan Q; Xuan L
    Contraception; 1984 Mar; 29(3):229-39. PubMed ID: 6734209
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Earth, motherhood, and the intrauterine device.
    Eschenbach DA
    Fertil Steril; 1992 Jun; 57(6):1177-9. PubMed ID: 1601138
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A comparison between Nova T and Copper T 200 Ag in Hungary.
    Batar I; Lampe L; Rakoczi I; Gati I; Allonen H
    Int J Gynaecol Obstet; 1987 Feb; 25(1):59-63. PubMed ID: 2883047
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The TCu 380A IUD and the frameless IUD "the FlexiGard": interim three-year data from an international multicenter trial. UNDP, UNFPA, and WHO Special Programme of Research, Development and Research Training in Human Reproduction, World Bank: IUD Research Group.
    Contraception; 1995 Aug; 52(2):77-83. PubMed ID: 8536451
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intrauterine contraception with copper and with levonorgestrel: a randomized study of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I; Alvarez F; Diaz J; Diaz S; el Mahgoub S; Coutinho E; Brache V; Diaz MM; Faundes A; Pavez M
    Contraception; 1984 Nov; 30(5):443-56. PubMed ID: 6440740
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Report on the sue of the Dalkon Shield intrauterine device.
    Sadovsky E; Yarkoni S; Anteby SO
    Contraception; 1974 Nov; 10(5):475-80. PubMed ID: 4448061
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pelvic infection: a comparison of the Dalkon shield and three other intrauterine devices.
    Snowden R; Pearson B
    Br Med J (Clin Res Ed); 1984 May; 288(6430):1570-3. PubMed ID: 6426647
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical evaluation of the TCu 380A IUD at six Latin American centers.
    Petta CA; Amatya R; Farr G
    Contraception; 1994 Jul; 50(1):17-25. PubMed ID: 7924319
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Performance of the copper T-380A intrauterine device in breastfeeding women.
    Chi IC; Potts M; Wilkens LR; Champion CB
    Contraception; 1989 Jun; 39(6):603-18. PubMed ID: 2666018
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intrauterine devices and pelvic inflammatory disease: meta-analyses of published studies, 1974-1990.
    Gareen IF; Greenland S; Morgenstern H
    Epidemiology; 2000 Sep; 11(5):589-97. PubMed ID: 10955413
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Side effects of intrauterine pessaries--a retrospective study].
    Voigt R; Wagnitz S; Stech D
    Geburtshilfe Frauenheilkd; 1991 Mar; 51(3):199-202. PubMed ID: 2055393
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Escherichia coli transport by Dalkon shield string. (Letter to the editor).
    Katayama KP
    JAMA; 1975 Sep; 233(9):950-1. PubMed ID: 12258500
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pregnancy after IUD use.
    Rioux JE; Cloutier D; Dupont P; Lamonde D
    Adv Contracept; 1986 Jun; 2(2):185-92. PubMed ID: 3776745
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Changes in copper and zinc serum levels in women wearing a copper TCu-380A intrauterine device.
    Imani S; Moghaddam-Banaem L; Roudbar-Mohammadi S; Asghari-Jafarabadi M
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):45-50. PubMed ID: 24304153
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Experience with three different models of the Copper T intrauterine contraceptive device in nulliparous women.
    Roy S; Cooper D; Mishell DR
    Am J Obstet Gynecol; 1974 Jun; 119(3):414-7. PubMed ID: 4827383
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical experience with the Dalkon Shield intrauterine device.
    Jones RW; Parker A; Elstein M
    Br Med J; 1973 Jul; 3(5872):143-5. PubMed ID: 4720765
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical experience with the Dalkon shield.
    Br Med J; 1973 Sep; 3(5879):542. PubMed ID: 4741614
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pelvic inflammatory disease and the Dalkon Shield.
    Layde PM
    JAMA; 1983 Aug; 250(6):796-7. PubMed ID: 6876335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.